AHIMA hopes data gathering and sharing will help address the issue.
Every day, more than 115 people in the United States die as a result of opioid overdose, according to the National Institute on Drug Abuse (NDA).
Tracing the origin of the crisis to the widespread distribution of opioid pain relievers in the 1990s, when pharmaceutical companies insisted that the drugs were not addictive, the NDA has reported that healthcare providers began prescribing them at greater rates – and that the opioids turned out to be highly addictive indeed.
Enter the American Health Information Management Association (AHIMA) and its data analytics practice council, which today is using data to help address the misuse of prescription opioids, which costs the U.S. an estimated $78.5 billion annually in terms of healthcare, lost productivity, addiction treatment, and the nation’s criminal justice system, according to today the Centers for Disease Control and Prevention (CDC).
So what can healthcare organizations do with this data analysis? And what is AHIMA doing to shed more light on this epidemic? For insight, we interviewed Lesley Kadlec, MA, RHIA, CHDA, who serves as director of Health Information Management (HIM) Practice Excellence at AHIMA, to learn how health data can be used to respond to the crisis and how and when it’s appropriate to share the data.
Buck: How can data be used to respond to the opioid crisis?
AHIMA: Health data analysts can use both real-time and retrospective data to understand physician prescribing patterns, prescription quantities (such as the number of pills prescribed per written prescription), and opioid refill rates – and to compare this data to the types of illnesses and surgeries (for which) opioid painkillers are being prescribed. Health records are rich with data, and data analysts can use their skills to tap into electronic health records and uncover patterns that help make the data actionable.
Buck: How is this data being collected?
AHIMA: The increased use of health IT, including the widespread use of electronic health records (EHRs), has resulted in an increase in data capture, including opioid prescribing information and data on abuse, overdoses, and use of overdose antidotes. Additionally, states that have a Prescription Drug Monitoring Program (PDMP) collect information on filled prescriptions for controlled substances, and that data is being made available to clinicians to assist them in making prescribing decisions.
Buck: How is the information from this data being shared in the field? In other words, what’s the feedback loop?
AHIMA: Clinical decision support tools are being deployed that allow real-time feedback to clinicians at the time of prescribing; for example, this includes integration of PDMPs with EHRs. Interactive dashboards are being used to provide internal and external data on a number of opioid-related statistics, such as emergency department visits, opioid-related deaths, neonatal addictions, etc.
Buck: Are there any examples of this? Any field research?
AHIMA: At least one state (Illinois) has launched a statewide dashboard to share information among healthcare providers, law enforcement, and community organizations to demonstrate how opioids are affecting its population and to get data into the hands of caregivers to help alleviate the crisis.
Buck: I assume the discussion is about prescription opioids?
AHIMA: While our team’s work to date has focused on prescriptive opioids, we recognize that the problem extends beyond prescribing to include nonprescriptive opioid use, though accurate data around nonprescriptive use is more difficult to obtain.
Buck: When was the AHIMA data analytics practice council formed, and are there other projects being undertaken at this time?
AHIMA: The AHIMA Data Analytics Practice Council was launched in January 2018. Many members of the Practice Council had served in volunteer roles on other informatics and data analytics practice councils and task forces in the past as well. The Data Analytics Practice Council is developing a number of articles for publication in the “Advancing Analytics” column for upcoming editions of the Journal of AHIMA, as well as recording Data Dive webinars (complimentary) and writing blog posts for the AHIMA Data Revolution blog.
Program Note:
Listen to Lesley Kadlec today on TalkTenTuesdays, 10-10:30 a.m. EST.
Federal officials are marking National Women’s Health Week with a call for awareness and reform to address stubborn disparities that have lingered historically – and
Let’s start today with some Quality Improvement Organization (QIO) issues, specifically pertaining to Kepro. First, I reported a few weeks ago that Kepro is changing
Please log in to your account to comment on this article.
Michelle Wieczorek explores challenges, strategies, and best practices to AI implementation and ongoing monitoring in the middle revenue cycle through real-world use cases. She addresses critical issues such as the validation of AI algorithms, the importance of human validation in machine learning, and the delineation of responsibilities between buyers and vendors.
Frank Cohen shows you how to leverage the Comprehensive Error Rate Testing Program (CERT) to create your own internal coding and billing risk assessment plan, including granular identification of risk areas and prioritizing audit tasks and functions resulting in decreased claim submission errors, reduced risk of audit-related damages, and a smoother, more efficient reimbursement process from Medicare.
Dr. Ronald Hirsch presents an essential “A to Z” review of Observation, including proper use for Medicare, Medicare Advantage, and commercial payers. He addresses the correct use of Observation in medical patients and surgical patients, and how to deal with the billing of unnecessary Observation services, professional fee billing, and more.
Explore the top-10 federal audit targets for 2024 in our webcast, “Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets,” featuring Certified Compliance Officer Michael G. Calahan, PA, MBA. Gain insights and best practices to proactively address risks, enhance compliance, and ensure financial well-being for your healthcare facility or practice. Join us for a comprehensive guide to successfully navigating the federal audit landscape.
This third session in the ICD10monitor 2025 IPPS Masterclass will feature a review of FY25 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from CDI expert Dr. Erica Remer.
This second session in the ICD10monitor 2025 IPPS Masterclass will feature a review of the FY25 changes to ICD-10-PCS codes, presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from CDI expert Dr. Erica Remer.
This first session in the ICD10monitor 2025 IPPS Masterclass will feature a review of FY25 changes to ICD-10-CM codes and guidelines, SDoH, CCs/MCCs and revisions to the MCE, presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from Dr. Erica Remer.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY25 Inpatient Prospective Payment System (IPPS) Final Rule, including new ICD-10-CM/PCS codes, plus insights, analysis and answers to questions from the country’s most respected subject matter experts.
Copyright © 2024 RACmonitor. Powered by MedLearn Media.
Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’ is just $99 for a limited time! Use code WorldHealth24 at checkout.
